PHILADELPHIA, June 3, 2019 – BIO 2019 – Signals Analytics, whose business intelligence platform connects disparate, external data with deep context to help brands better align with evolving trends, announces the launch of Pharma Playbook™. The latest advance in business-driving, on-demand data analytics from the winner of Frost & Sullivan's 2019 Technology Innovation Award - Data Analytics, Pharma Playbook provides life sciences companies with direct insights, disrupting the industry's current approach to data analytics.
Dr. Shlomi Madar, Vice President, Healthcare Solutions for Signals Analytics, is available throughout the event in the BIO 2019 partnering suite to demonstrate and discuss Pharma Playbook.
"Gaining access to comprehensive, high quality data is a good starting point. However, having to collate, harmonize and analyze the data is proven to be a daunting and, in some case, an impossible task," said Dr. Madar. "Rather than spending precious time connecting and processing data, the Pharma Playbook was designed to help multiple Pharma stakeholders to focus their efforts on interpreting the data, extracting insights, and making evidence-based decisions."
Pharma Playbook from Signals Analytics enables users to:
Uncover competitors' strategies: Identify threats and benchmark your market and pipeline performance
Prioritize your R&D pipeline: Benchmark clinical and preclinical concepts, reducing the opportunity cost of your pipeline to achieve a competitive product when it hits the market
Surface early innovation: Identify early drugs/concepts across categories and therapeutic areas
Identify partnerships and M&A opportunities: Landscape, identify and benchmark potential companies for licensing, partnering and acquisition purposes
Scorecard Analysis: A set of advanced dashboards that offer a one-of-a-kind connectivity between disparate data sources and sophisticated ranking formulas that will allow you to surface unique insights backed by evidence. The output can be used as an end-to-end infographic for a variety of business questions.
Pharma Playbook is rooted in the "battlefield to the board room" technology that has proven to be a game-changer for Signals Analytics' clients. While in a military intelligence unit, Signals Analytics co-founders Gil Sadeh and Kobi Gershoniexperienced digital transformation as part of a task force that utilized open source (OSINT, signals (SIGINT) and human (HUMINT) intelligence to enable covert operations. They co-founded Signals Analytics based on the realization that the same concepts, processes and technologies deployed in the battlefield could be utilized to make better business decisions.
The Signals Analytics team developed a solution named Signals Playbook™, an intelligence platform that aids business executives in decision-making. The platform's unique design applies proven military principles of Open Source Intelligence to a range of industries.
With next-generation advanced analytics, Signals Analytics powers the future of market intelligence with the scale and speed of AI. The configurable data platform connects and classifies countless rich, external sources into unified contextual data, and augments analytic applications with unparalleled accuracy and scale. Patented machine learning, NLP and data automation technologies leapfrog traditional approaches of data collection and management to help organizations maximize the impact of advanced analytics and harness the power of external data to drive successful business outcomes. Business users, consumer and market insights teams and data & analytics organizations leverage the platform to surface powerful trends and predictive insights and benefit from business-ready applications and integrations of the data into their business intelligence environments. Trusted by an impressive roster of global brands including Procter & Gamble, Nestle, Johnson & Johnson, Bayer, Roche, Mars and others who experience higher sustainable growth, faster time to insight and other data-driven benefits, Signals Analytics is redefining the world of market intelligence. For more information visit www.signals-analytics.com